Considering the specific role of IFN played in cancer immunotherapy, we tried to investigate the relationship between the novel signature with immunotherapy response, especially the immune checkpoints and immune status in ovarian cancer. The gene discussed is IFNA1; the disease is ovarian carcinoma.